AstraZeneca says no share repurchases will take place in 2013 AstraZeneca said its board has decided that no share repurchases will take place in 2013 in order to maintain the flexibility to invest in the business
News For AZN From The Last 14 Days
Check below for free stories on AZN the last two weeks.
Leerink's biotech/pharma analysts hold an analyst/industry conference call Biotech Analyst Kozul and Major Pharmaceuticals Analyst Fernandez provide a review of Emerging 3rd Generation Tyrosine Kinas Inhibitors (TKI) Data for Non-Small Cell Lung Cancer (NSCLC) on an Analyst/Industry conference call. Relevant companies AstraZeneca (AZN) and Clovis Oncology (CLVS) may be discussed on the Analyst/Industry conference call to be held on December 12 at 1 pm.